OBI Pharma, Inc. engages in the development and licensing of novel therapeutic agents for unmet medical needs against cancer. Its products include Adagloxad Simolenin, which is a late-stage novel active immune-oncology Globo Series-based therapeutic vaccine for the treatment of epithelial cancers, such as breast, ovarian, lung, prostate, colon, gastric, and pancreatic cancer. The company was founded by Michael N. Chang on April 29, 2002 and is headquartered in Taipei, Taiwan.

The Max Planck Society for the Advancement of Science (German: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V.; abbreviated MPG) is a non-governmental and non-profit association of Research Institutes publicly funded by the federal and the state governments of Germany. Additionally, the Max Planck Society and its Institutes receive third party funding from public and private contributions and from the European Union. The world leading organization is named in honor of its former president, theoretical physicist Max Planck. The 86 Institutes and Research Facilities of the Max Planck Society (as of 2020) conduct basic research in the natural sciences, life sciences, social sciences, and the arts and humanities. They have a total staff of approximately 24,000 permanent employees, including 15,000 scientists, and around 5,000 non-tenured scientists and guests. As of December 31, 2018, the proportion of female employees was 44.4 percent. The Max Planck Society (with its 86 Max Planck Institutes) has a world-leading reputation as a science and technology research organization, with more than 33 Nobel Prizes awarded to its scientists, and is widely regarded as one of the foremost basic research organizations in the world.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Denka Corp., part of Denka Co., Ltd., is an American company located in New York, NY. The firm manufactures and distributes chemical products.

The University Hospital of Basel (German: Universitätsspital Basel, USB), in Basel, is one of the five university hospitals of Switzerland. Since 1842 it is located in a former palace, the Markgräflerhof.

Glycotope GmbH operates as a biotechnology company to develop pharmaceutical therapeutics and nutrition additives. It focuses on the optimization and humanization of therapeutically relevant sugar structures on biopharmaceuticals known as glycosylation and on the development of innovative antibodies targeting glycostructures on cell surfaces. The company was founded by Steffen Goletz and Andreas Eckert in Febraury 2001 and is headquartered in Berlin, Germany.

Noastec provides consistent support activities from research and development to commercialization.

Manufactures pharmaceuticals

Denka Seiken started out as a manufacturer of vaccines for human use. Later, they became involved with diagnostic reagents and expanded the scope of their business activities to meet the needs of their customers, offering product lines, service, and knowledge to hospitals and clinics. Denka Seiken has established itself as a manufacturer of vaccines and diagnostic reagents.\nDenka Seiken is engaged in research and development in such fields as bacteriology and virology, immunochemistry, clinical chemistry and food-related diagnostic reagents, in addition to vaccines against influenza, DPT, and other illnesses.

Develops and researches products to monitor and treat cancer

Shanghai Liangrun Biomedical Technology Co., Ltd., established on 2013-09-09, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:engaged in biotechnology,Medical Technology,medical instruments,Technology development in the field of medical technology expertise,Technical Services,technology transfer,technical consulting,Technology Promotion,Technology Exchange,Production of Class I Medical Devices,Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals),First,Class II medical device,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),Instrumentation,plastic products,Fiberglass and its products,High-performance non-ferrous metals and alloy materials,Sales of packaging materials and products,Engaged in the import and export of goods and technology,Re-export trade,Trade and trade agency for enterprises in the region.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Ramot at Tel Aviv University Ltd. operates as a technology transfer company of Tel Aviv University (TAU). It provides legal and commercial frameworks for inventions made by TAU faculty, students, and researchers. The firm licenses the university's intellectual property to third parties through agreements; facilitates collaborative research partnerships between business partners and TAU researchers; establishes a company; and forms joint ventures that promote TAU technologies. The company was founded in 1973 and is headquartered in Tel Aviv, Israel.

Bioventures LLC is an American private company located in Tulsa, OK, that develops pharmaceutical products. The firm was founded in 2004.

Geron is a biotechnology company that specializes in developing blood cancer treatments for hematologic malignancies. The company's Imetelstat, an investigational first-in-class telomerase inhibitor, harnesses Nobel Prize-winning science in a treatment that may change the underlying course of these diseases. Geron was established in 1990 and is headquartered in Foster City, California.